— Know what they know.
Not Investment Advice

ACUT OTC

Accustem Sciences Inc.
1W: +12.5% 1M: -15.6% 3M: -52.7% YTD: -83.4% 1Y: -91.0% 3Y: -86.5%
$0.14
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 36 · $2.2M mcap · 10M float · 0.040% daily turnover · Short 65% of daily vol

Balance Sheet Trends

Total Assets
$51K -62.0% ▼
4Y CAGR: -57.6%
Total Liabilities
$3M +49.8% ▲
4Y CAGR: +179.2%
Shareholders Equity
-$3M -56.9% ▼
Cash & Investments
$5K -76.5% ▼
Total Debt
$25K -54.8% ▼
Net Debt
$20K -41.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$2M$0$734K$21K$5K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$0$0$734K$21K$5K
Net Receivables$1M$1M$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$30K$0$0
Total Current Assets$1M$1M$932K$130K$50K
Property, Plant & Equip.$0$0$8K$4K$418
Goodwill & Intangibles$3M$0$0$0$0
Long-Term Investments$207K$205K$0$0$0
Other Non-Current Assets-$3M$0$0$0$0
Total Non-Current Assets$207K$205K$8K$4K$418
Total Assets$2M$2M$940K$134K$51K
— Liabilities —
Accounts Payable$0$389K$312K$578K$805K
Short-Term Debt$0$0$107K$56K$25K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$314K$0$1M$2M
Total Current Liabilities$55K$703K$1M$2M$3M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$389K$312K$0$0
Total Liabilities$55K$703K$1M$2M$3M
— Equity —
Common Stock$10K$10K$11K$11K$12K
Retained Earnings-$54K-$725K-$4M-$7M-$8M
Accumulated OCI$79K$67K$0$0$0
Total Stockholders Equity$2M$856K-$140K-$2M-$3M
Total Liabilities & Equity$2M$2M$940K$134K$51K
— Key Metrics —
Total Debt$0$0$107K$56K$25K
Net Debt-$2M$0-$627K$34K$20K
Total Investments$207K$205K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms